| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Animal agents and vectors of human disease
|
Mitchell, G.H.
|
|
1986
|
4 |
3 |
p. 204-
1 p.
|
article
|
| 2 |
Anticancer vaccine derived from animal tissue by purification and loading with immune-homeostatic substances
|
|
|
1986
|
4 |
3 |
p. 198-
1 p.
|
article
|
| 3 |
Antigenic GM2 ganglioside conjugate prepared by conjugating oligosaccharide portion to protein carrier; vaccine and anti-tumor activity
|
|
|
1986
|
4 |
3 |
p. 198-
1 p.
|
article
|
| 4 |
Attenuated smallpox vaccine strain
|
|
|
1986
|
4 |
3 |
p. 200-
1 p.
|
article
|
| 5 |
Babesiosis vaccine production from a soluble antigenic extract of infected erythrocytes by isolation using electrophoresis
|
|
|
1986
|
4 |
3 |
p. 197-
1 p.
|
article
|
| 6 |
Calendar
|
|
|
1986
|
4 |
3 |
p. 208-
1 p.
|
article
|
| 7 |
Canine coronavirus vaccine
|
|
|
1986
|
4 |
3 |
p. 200-
1 p.
|
article
|
| 8 |
Characterization and immunogenicity of HSV-1 antigens obtained following zwitterionic detergent treatment
|
Mukhlis, Faiza A.
|
|
1986
|
4 |
3 |
p. 191-196
6 p.
|
article
|
| 9 |
Chemical modification of Pasteurella multocida for use as vaccine
|
|
|
1986
|
4 |
3 |
p. 198-
1 p.
|
article
|
| 10 |
Comparative clinical study of a new 17D thermostable yellow fever vaccine
|
Roche, J.C.
|
|
1986
|
4 |
3 |
p. 163-165
3 p.
|
article
|
| 11 |
Conference report: Guidelines for the development of recombinant vaccinia viruses for use as vaccines
|
|
|
1986
|
4 |
3 |
p. 204-
1 p.
|
article
|
| 12 |
Development of an attenuated strain of chikungunya virus for use in vaccine production
|
Levitt, Neil H.
|
|
1986
|
4 |
3 |
p. 157-162
6 p.
|
article
|
| 13 |
Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen
|
Alving, Carl R.
|
|
1986
|
4 |
3 |
p. 166-172
7 p.
|
article
|
| 14 |
Effects of elevated temperatures on the opacity and toxicity of pertussis vaccines manufactured with different inactivating agents
|
Gupta, R.K.
|
|
1986
|
4 |
3 |
p. 185-190
6 p.
|
article
|
| 15 |
Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials
|
Meadors III, Gilcin F.
|
|
1986
|
4 |
3 |
p. 179-184
6 p.
|
article
|
| 16 |
Feline infectious peritonitis vaccine
|
|
|
1986
|
4 |
3 |
p. 200-
1 p.
|
article
|
| 17 |
Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors
|
|
|
1986
|
4 |
3 |
p. 199-
1 p.
|
article
|
| 18 |
Inactivated canine coronavirus vaccine
|
|
|
1986
|
4 |
3 |
p. 200-
1 p.
|
article
|
| 19 |
Inactivated pigeon herpes virus vaccine from chicken fibroblast cell culture
|
|
|
1986
|
4 |
3 |
p. 199-
1 p.
|
article
|
| 20 |
Inactivated poultry plague vaccine from virus Newcastle disease culture in incubated hen egg
|
|
|
1986
|
4 |
3 |
p. 199-
1 p.
|
article
|
| 21 |
Injectable Bordetella bronchiseptica vaccine for preventing atrophic rhinitis and turbinate atrophy in pigs
|
|
|
1986
|
4 |
3 |
p. 197-
1 p.
|
article
|
| 22 |
Long-term antibody response after measles vaccination in an isolated arctic society in Greenland
|
Pedersen, I.R.
|
|
1986
|
4 |
3 |
p. 173-178
6 p.
|
article
|
| 23 |
New DNA sequences of Epstein-Barr virus genome useful in protein expression for viral antibody detection in blood serum, for vaccine production and as DNA probe
|
|
|
1986
|
4 |
3 |
p. 199-200
2 p.
|
article
|
| 24 |
New immunologically active pure synthetic peptides useful as a malaria vaccine; Plasmodium falciparum
|
|
|
1986
|
4 |
3 |
p. 197-198
2 p.
|
article
|
| 25 |
New vaccine against gonorrhea containing peptide sequences of Neisseria gonorrhoeae MS11 (Tr) pilus protein linked to a neutral carrier
|
|
|
1986
|
4 |
3 |
p. 198-
1 p.
|
article
|
| 26 |
Oral vaccine production by inactivating virus in the presence of protective compounds from the culture medium, adding further stabilizer and then freeze-drying
|
|
|
1986
|
4 |
3 |
p. 199-
1 p.
|
article
|
| 27 |
Preparation of cholera toxin subunit-B for use in vaccine preparation
|
|
|
1986
|
4 |
3 |
p. 198-199
2 p.
|
article
|
| 28 |
Purifying hepatitis B surface antigen from recombinant cell cultures by separating cells, fractional protein precipitation of the filtrate and purification on an anion exchanger
|
|
|
1986
|
4 |
3 |
p. 198-
1 p.
|
article
|
| 29 |
Stimulation of cytokine production in mice using deacetylated chitin
|
Nishimura, Keiko
|
|
1986
|
4 |
3 |
p. 151-156
6 p.
|
article
|
| 30 |
Strain-independent inactivated influenza vaccine production by removal of the hemagglutinin heavy HA1 chain
|
|
|
1986
|
4 |
3 |
p. 199-
1 p.
|
article
|
| 31 |
The quest for a herpes simplex virus vaccine: background and recent developments
|
Hall, M.J.
|
|
1986
|
4 |
3 |
p. 138-150
13 p.
|
article
|
| 32 |
The WHO programme for vaccine development
|
|
|
1986
|
4 |
3 |
p. 201-203
3 p.
|
article
|
| 33 |
Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis
|
|
|
1986
|
4 |
3 |
p. 200-
1 p.
|
article
|
| 34 |
Vaccine against Neisseria meningitidis gp. B infection containing a single serotype 2b antigen
|
|
|
1986
|
4 |
3 |
p. 197-
1 p.
|
article
|
| 35 |
Vaccine against rotavirus disease prepared from live attenuated immunogenic rhesus rotavirus
|
|
|
1986
|
4 |
3 |
p. 200-
1 p.
|
article
|
| 36 |
Vaccine against Schistosoma mansoni containing soluble antigen from larvae or adults
|
|
|
1986
|
4 |
3 |
p. 199-
1 p.
|
article
|
| 37 |
Vaccine against vesicular stomatitis virus infection containing virus inactivated by irradiation with u.v. light in the presence of furocoumarin
|
|
|
1986
|
4 |
3 |
p. 197-
1 p.
|
article
|
| 38 |
Vaccine and method of immunizing against herpes simplex virus (types 1 and 2) using intertypic vaccinal recombinant virus strain
|
|
|
1986
|
4 |
3 |
p. 197-
1 p.
|
article
|
Journal description